1007-3418
2012 Issue 2
Optimized strategy in chronic hepatitis B antiviral treatment
GAO Zhi-liang;XIE Dong-ying;LIN Bing-liang;ZHAO Zhi-xin;XIE Qi-feng;HUANG Zhan-lian
GAO Zhi-liang;XIE Dong-ying;LIN Bing-liang;ZHAO Zhi-xin;XIE Qi-feng;HUANG Zhan-lian
..............page:154-157
Establishment of the Chang liver cell line stably overexpressing human UCP2 gene and its effect on mitochondrial membrane potential and reactive oxygen species
GUAN Li-li;WANG Yao-feng;GONG Dezheng;YUAN Bo;WU Qiong;ZHU Liang;JIA Xiao-li;LIU Ming-chuan;ZHAO Jie;ZOU Yuan
GUAN Li-li;WANG Yao-feng;GONG Dezheng;YUAN Bo;WU Qiong;ZHU Liang;JIA Xiao-li;LIU Ming-chuan;ZHAO Jie;ZOU Yuan
..............page:131-135
Clinical analysis of intrahepatic biliary tract abscesses
HU Lihua;CHEN Peng;TIA N L in;ZHANG Pei-yi
HU Lihua;CHEN Peng;TIA N L in;ZHANG Pei-yi
..............page:149-150
Clinical application of contrast-enhanced ultrasound, magnetic resonance cholangiopancreatography and diffusion-weighted imaging for diagnosis of ischemic-type biliary lesions after liver transplantation
WANG Jin;LIU Jing-jing;HU Bing;HE BingJun;YAN Rong-hua;SU Zhong-zhen;JIANG Zai-bo;SHAN Hong
WANG Jin;LIU Jing-jing;HU Bing;HE BingJun;YAN Rong-hua;SU Zhong-zhen;JIANG Zai-bo;SHAN Hong
..............page:146-148
Influences of warming kidney prescription on antiviral therapeutic efficacy and creatine kinase in telbivudinetreated HBeAg-positive chronic hepatitis B patients
HU Xiao-yu;ZHANG Yang;LIU Guang-wei;NIE Hongming;FAN Xin-jian;ZHONGSen
HU Xiao-yu;ZHANG Yang;LIU Guang-wei;NIE Hongming;FAN Xin-jian;ZHONGSen
..............page:93-97
Ursodeoxycholic acid treatment to resolve abnormal function in liver transplant recipients
WANG Wen-tao;YANG Jian;YAN Lvnan;LI Bo;WEN Tian-fu
WANG Wen-tao;YANG Jian;YAN Lvnan;LI Bo;WEN Tian-fu
..............page:144-145
Efficacy of lamivudine and adefovir de novo combination therapy or after mono-therapy in chronic hepatitis B patients
MA Xiao-jun;CHEN Xiao-ping;CHEN Xue-fu;CHEN Wen-li;HUANG Jing;CHEN Ren;LUO Xiao-dan;MA Hong-ying
MA Xiao-jun;CHEN Xiao-ping;CHEN Xue-fu;CHEN Wen-li;HUANG Jing;CHEN Ren;LUO Xiao-dan;MA Hong-ying
..............page:98-102
Clinical analysis of HBsAg clearance in ten chronic hepatitis B patients treated with nucleoside analogs
XTU Chun;LI Bai-jun;WEI Ni
XTU Chun;LI Bai-jun;WEI Ni
..............page:136-138
Abnormal expression of intercellular adhesion molecule-1 and characteristics of invasive growth and metastasis in hepatocellular carcinoma
YANG Jun-ling;YAO Deng-fu
YANG Jun-ling;YAO Deng-fu
..............page:158-160
Optimized strategy: new concept in antiviral therapy for chronic hepatitis B
WANG Yu-ming;CHENG Lin
WANG Yu-ming;CHENG Lin
..............page:82-85
Construction and functional characterization of a monocistronic replicon based on the HCV genotype 2a promotor
LI Xue-li;LEI Yu;ZHONG Shan;PENG Feng-ying;ZHOU Zhi;LI Kui;REN Hong
LI Xue-li;LEI Yu;ZHONG Shan;PENG Feng-ying;ZHOU Zhi;LI Kui;REN Hong
..............page:103-107
..............page:88,107,138,148,157,160,153,145,143,97,中插1
..............page:86-88
Dynamic change of lipid peroxidation-related protein expression and the intervention effects of Yiguanjian Decoction in a rat model of CCl4-induced liver fibrosis
TAO Qing;WANGXiao-ning;MU Yong-ping;FENG Qin;PENG Jing-hua;LIU Ping;FU Wen-wei;ZHANG Wen-meng;HU Yi-yang
TAO Qing;WANGXiao-ning;MU Yong-ping;FENG Qin;PENG Jing-hua;LIU Ping;FU Wen-wei;ZHANG Wen-meng;HU Yi-yang
..............page:116-121
..............page:81
Sorafenib and octreotide combination therapy can inhibit proliferation of and induce apoptosis in human hepatoma cells
LI Zhao-dong;LIU Yu;LIAO Yu;ZUO Guo-qing
LI Zhao-dong;LIU Yu;LIAO Yu;ZUO Guo-qing
..............page:126-130
Non-invasive diagnostic indicators for predicting esophagealgastric varices in patients with hepatitis B-related cirrhosis
HAN Ying;LIU Yan-min;LIAO Hui-yu;HU Zhong-jie;FAN Chun-lei;LI Lei;DING Hui-guo
HAN Ying;LIU Yan-min;LIAO Hui-yu;HU Zhong-jie;FAN Chun-lei;LI Lei;DING Hui-guo
..............page:141-143
Nucleos(t)ides analog block HBV mother-to-child transmission in pregnancy HBV carriers-agreement and challenges
DOU Xiaoguang;D1NG Yang;SHENG Qiu-ju
DOU Xiaoguang;D1NG Yang;SHENG Qiu-ju
..............page:89-92
Efficacy of antiviral drugs in patients with hepatitis C liver cirrhosis after splenectomy and extensive esophagogastrie devascularization
XIAO Er-hui;CAO Qing;CAO Yong-ge;KANG Yi;WEI Jun-feng;LIU Jun-ping;DING Gang-qiang;HOU Huanrong;SHANG Jia
XIAO Er-hui;CAO Qing;CAO Yong-ge;KANG Yi;WEI Jun-feng;LIU Jun-ping;DING Gang-qiang;HOU Huanrong;SHANG Jia
..............page:139-140
Peg-IFNα-2a/RBV antiviral efficacy in cirrhotic hepatitis C patients after splenectomy or partial splenic embolization
XIE Yu-mei;LI Bing;MA Li;PAN Lei;WEI Xin;PENG Mei-juan;HAO Chun-qiu;ZHANG Ying;BAI Xue-fan;KANG Wen-zhen;JIA Zhan-sheng
XIE Yu-mei;LI Bing;MA Li;PAN Lei;WEI Xin;PENG Mei-juan;HAO Chun-qiu;ZHANG Ying;BAI Xue-fan;KANG Wen-zhen;JIA Zhan-sheng
..............page:112-115
Diagnostic efficacy of an ultrasound quantitative method in a rat model of experimental liver fibrosis
CHEN Ming-li;WANG Yi;YANG Yong-ming;QIN Qian-miao;CAI Ye-hua;ZHOU Guo-hui
CHEN Ming-li;WANG Yi;YANG Yong-ming;QIN Qian-miao;CAI Ye-hua;ZHOU Guo-hui
..............page:122-125
Serum sodium concentration profile for cirrhotic patients and its effect on the prognostic value of the MELD score
ZHANG Jun-yong;QINCheng-yong;JIAJi-dong;WANG Bao-en
ZHANG Jun-yong;QINCheng-yong;JIAJi-dong;WANG Bao-en
..............page:108-111
A report from the third symposium on the hots and difficult points during antiviral therapy for chronic hepatitis B
YUAN Ping-ge;SUN Yu-hang;PENG Zhi;ZHANG Da-zhi
YUAN Ping-ge;SUN Yu-hang;PENG Zhi;ZHANG Da-zhi
..............page:151-153